Invention Grant
- Patent Title: Polyomavirus neutralizing antibodies
-
Application No.: US17502910Application Date: 2021-10-15
-
Publication No.: US11639378B2Publication Date: 2023-05-02
- Inventor: Johanna Abend , Zorica Dragic , Adam Lloyd Feire , Mark Knapp , Steven Kovacs , Elisabetta Traggiai , Lichun Wang , Yongqiang Wang , Danqing Wu , Qilong Wu , Fangmin Xu
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Cooley LLP
- Priority: WOPCT/CN2015/089764 20150916
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/08 ; A61K39/42 ; A61K45/06 ; A61K9/19
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Public/Granted literature
- US20220363735A1 Polyomavirus Neutralizing Antibodies Public/Granted day:2022-11-17
Information query
